Aspirin Decreases the Prevalence and Severity of Heterotopic Ossification After 1-Stage Bilateral Total Hip Arthroplasty for Osteoarthrosis

Journal of Arthroplasty

Volumn 24, Issue 2, 2009, Pages 226-232

  Bek, Doǧan ^a   Beksaç, Burak ^a   Della Valle, Alejandro González ^a   Sculco, Thomas P ^a   Salvati, Eduardo A ^a  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

aspirin; heterotopic ossification; total hip arthroplasty

Indexed keywords

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT, HIP; ASPIRIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OSSIFICATION, HETEROTOPIC; OSTEOARTHRITIS, HIP; PREVALENCE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; THROMBOSIS; WARFARIN;

EID: 58249139378     PISSN: 08835403     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arth.2007.11.008     Document Type: Article

References (67)

1. Pagnani M.J., Pellicci P.M., and Salvati E.A. Effect of aspirin on heterotopic ossification after total hip arthroplasty in men who have osteoarthrosis. J Bone Joint Surg Am 73 (1991) 924
2. Kjaersgaard-Andersen P., Hougaard K., Linde F., et al. Heterotopic bone formation after total hip arthroplasty in patients with primary or secondary coxarthrosis. Orthopedics 13 (1990) 1211
3. Knahr K., Salzer M., Eyb R., et al. Heterotopic ossification with total hip endoprostheses in various models of thrombosis prophylaxis. J Arthroplasty 3 (1988) 1
4. Freiberg A.A., Cantor R., and Freiberg R.A. The use of aspirin to prevent heterotopic ossification after total hip arthroplasty. A preliminary report. Clin Orthop Relat Res (1991) 93
5. Kjaersgaard-Andersen P., and Ritter M.A. Short-term treatment with nonsteroidal antiinflammatory medications to prevent heterotopic bone formation after total hip arthroplasty. A preliminary report. Clin Orthop Relat Res (1992) 157
6. Knelles D., Barthel T., Karrer A., et al. Prevention of heterotopic ossification after total hip replacement. A prospective, randomised study using acetylsalicylic acid, indomethacin and fractional or single-dose irradiation. J Bone Joint Surg Br 79 (1997) 596
7. Neal B.C., Rodgers A., Clark T., et al. A systematic survey of 13 randomized trials of non-steroidal anti-inflammatory drugs for the prevention of heterotopic bone formation after major hip surgery. Acta Orthop Scand 71 (2000) 122
8. Bombelli R. Osteoarthritis of the hip: Classification and pathogenesis: the role of osteotomy as a consequent therapy (1983), Springer, Berlin
9. Brooker A.F., Bowerman J.W., Robinson R.A., et al. Ectopic ossification following total hip replacement. Incidence and a method of classification. J Bone Joint Surg Am 55 (1973) 1629
10. Pellicci P.M., Bostrom M., and Poss R. Posterior approach to total hip replacement using enhanced posterior soft tissue repair. Clin Orthop (1998) 224
11. Beksac B., Gonzalez Della Valle A., Anderson J., et al. Symptomatic thromboembolism after one-stage bilateral THA with a multimodal prophylaxis protocol. Clin Orthop Relat Res (2007) [electronic publication ahead of print]
12. Beksac B., Gonzalez Della Valle A., and Salvati E.A. Thromboembolic disease after total hip arthroplasty: who is at risk?. Clin Orthop Relat Res 453 (2006) 211
13. Rosendahl S., Christoffersen J.K., and Norgaard M. Para-articular ossification following hip replacement. 70 arthroplasties ad modum Moore using McFarland's approach. Acta Orthop Scand 48 (1977) 400
14. Iorio R., and Healy W.L. Heterotopic ossification after hip and knee arthroplasty: risk factors, prevention, and treatment. J Am Acad Orthop Surg 10 (2002) 409
15. Ritter M.A., and Vaughan R.B. Ectopic ossification after total hip arthroplasty. Predisposing factors, frequency, and effect on results. J Bone Joint Surg Am 59 (1977) 345
16. Eggli S., Rodriguez J., and Ganz R. Heterotopic ossification in total hip arthroplasty: the significance for clinical outcome. Acta Orthop Belg 66 (2000) 174
17. Kjaersgaard-Andersen P., Steinke M.S., Hougaard K., et al. Heterotopic bone formation following hip arthroplasty. A retrospective study of 65 bilateral cases. Acta Orthop Scand 62 (1991) 223
18. Duck H.J., and Mylod Jr. A.G. Heterotopic bone in hip arthroplasties. Cemented versus noncemented. Clin Orthop Relat Res (1992) 145
19. Higo T., Mawatari M., Shigematsu M., et al. The incidence of heterotopic ossification after cementless total hip arthroplasty. J Arthroplasty 21 (2006) 852
20. Eggli S., and Woo A. Risk factors for heterotopic ossification in total hip arthroplasty. Arch Orthop Trauma Surg 121 (2001) 531
21. Goel A., and Sharp D.J. Heterotopic bone formation after hip replacement. The influence of the type of osteoarthritis. J Bone Joint Surg Br 73 (1991) 255
22. Williams E., Taylor A.R., Arden G.P., et al. Arthroplasty of the hip in ankylosing spondylitis. J Bone Joint Surg Br 59-B (1977) 393
23. Blasingame J.P., Resnick D., Coutts R.D., et al. Extensive spinal osteophytosis as a risk factor for heterotopic bone formation after total hip arthroplasty. Clin Orthop Relat Res 191 (1981)
24. Guillemin F., Mainard D., Rolland H., et al. Antivitamin K prevents heterotopic ossification after hip arthroplasty in diffuse idiopathic skeletal hyperostosis. A retrospective study in 67 patients. Acta Orthop Scand 66 (1995) 123
25. Kjaersgaard-Andersen P., and Ritter M.A. Prevention of formation of heterotopic bone after total hip arthroplasty. J Bone Joint Surg Am 73 (1991) 942
26. Foster D.E., and Hunter J.R. The direct lateral approach to the hip for arthroplasty. Advantages and complications. Orthopedics 10 (1987) 274
27. Bischoff R., Dunlap J., Carpenter L., et al. Heterotopic ossification following uncemented total hip arthroplasty. Effect of the operative approach. J Arthroplasty 9 (1994) 641
28. Amstutz H.C., Beaule P.E., Dorey F.J., et al. Metal-on-metal hybrid surface arthroplasty: two to six-year follow-up study. J Bone Joint Surg Am 86 (2004) 28
29. DeLee J., Ferrari A., and Charnley J. Ectopic bone formation following low friction arthroplasty of the hip. Clin Orthop Relat Res 53 (1976)
30. Thomas B.J. Heterotopic bone formation after total hip arthroplasty. Orthop Clin North Am 23 (1992) 347
31. Board T.N., Karva A., Board R.E., et al. The prophylaxis and treatment of heterotopic ossification following lower limb arthroplasty. J Bone Joint Surg Br 89 (2007) 434
32. Hannallah D., Peng H., Young B., et al. Retroviral delivery of Noggin inhibits the formation of heterotopic ossification induced by BMP-4, demineralized bone matrix, and trauma in an animal model. J Bone Joint Surg Am 86-A (2004) 80
33. Tozun R., Pinar H., Yesiller E., et al. Indomethacin for prevention of heterotopic ossification after total hip arthroplasty. J Arthroplasty 7 (1992) 57
34. Sodemann B., Persson P.E., and Nilsson O.S. Prevention of periarticular heterotopic ossification following total hip arthroplasty. Clinical experience with indomethacin and ibuprofen. Arch Orthop Trauma Surg 107 (1988) 329
35. Cella J.P., Salvati E.A., and Sculco T.P. Indomethacin for the prevention of heterotopic ossification following total hip arthroplasty. Effectiveness, contraindications, and adverse effects. J Arthroplasty 3 (1988) 229
36. Persson P.E., Sodemann B., and Nilsson O.S. Preventive effects of ibuprofen on periarticular heterotopic ossification after total hip arthroplasty. A randomized double-blind prospective study of treatment time. Acta Orthop Scand 69 (1998) 111
37. Vielpeau C., Joubert J.M., and Hulet C. Naproxen in the prevention of heterotopic ossification after total hip replacement. Clin Orthop Relat Res (1999) 279
38. Gebuhr P., Soelberg M., Orsnes T., et al. Naproxen prevention of heterotopic ossification after hip arthroplasty. A prospective control study of 55 patients. Acta Orthop Scand 62 (1991) 226
39. Wahlstrom O., Risto O., Djerf K., et al. Heterotopic bone formation prevented by diclofenac. Prospective study of 100 hip arthroplasties. Acta Orthop Scand 62 (1991) 419
40. Jockheck M., Willms R., Volkmann R., et al. Prevention of periarticular heterotopic ossification after endoprosthetic hip joint replacement by means of diclofenac. Arch Orthop Trauma Surg 117 (1998) 337
41. Grohs J.G., Schmidt M., and Wanivenhaus A. Selective COX-2 inhibitor versus indomethacin for the prevention of heterotopic ossification after hip replacement: a double-blind randomized trial of 100 patients with 1-year follow-up. Acta Orthop 78 (2007) 95
42. Saudan M., Saudan P., Perneger T., et al. Celecoxib versus ibuprofen in the prevention of heterotopic ossification following total hip replacement: a prospective randomised trial. J Bone Joint Surg Br 89 (2007) 155
43. Sell S., Phillips O., and Handel M. No difference between two doses of diclofenac in prophylaxis of heterotopic ossifications after total hip arthroplasty. Acta Orthop Scand 75 (2004) 45
44. Fransen M., and Neal B. Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty. Cochrane Database Syst Rev (2004) CD001160
45. Fransen M., Anderson C., Douglas J., et al. Safety and efficacy of routine postoperative ibuprofen for pain and disability related to ectopic bone formation after hip replacement surgery (HIPAID): randomised controlled trial. BMJ 333 (2006) 519
46. Romano C.L., Duci D., Romano D., et al. Celecoxib versus indomethacin in the prevention of heterotopic ossification after total hip arthroplasty. J Arthroplasty 19 (2004) 14
47. Barthel T., Baumann B., Noth U., et al. Prophylaxis of heterotopic ossification after total hip arthroplasty: a prospective randomized study comparing indomethacin and meloxicam. Acta Orthop Scand 73 (2002) 611
48. Maloney W.J., Jasty M., Willett C., et al. Prophylaxis for heterotopic bone formation after total hip arthroplasty using low-dose radiation in high-risk patients. Clin Orthop Relat Res (1992) 230
49. Healy W.L., Lo T.C., Covall D.J., et al. Single-dose radiation therapy for prevention of heterotopic ossification after total hip arthroplasty. J Arthroplasty 5 (1990) 369
50. Howell S.J., and Shalet S.M. Spermatogenesis after cancer treatment: damage and recovery. J Natl Cancer Inst Monogr (2005) 12
51. Coventry M.B., and Scanlon P.W. The use of radiation to discourage ectopic bone. A nine-year study in surgery about the hip. J Bone Joint Surg Am 63 (1981) 201
52. Chao S.T., Lee S.Y., Borden L.S., et al. External beam radiation helps prevent heterotopic bone formation in patients with a history of heterotopic ossification. J Arthroplasty 21 (2006) 731
53. Padgett D.E., Holley K.G., Cummings M., et al. The efficacy of 500 CentiGray radiation in the prevention of heterotopic ossification after total hip arthroplasty: a prospective, randomized, pilot study. J Arthroplasty 18 (2003) 677
54. Pellegrini Jr. V.D., Konski A.A., Gastel J.A., et al. Prevention of heterotopic ossification with irradiation after total hip arthroplasty. Radiation therapy with a single dose of eight hundred centigray administered to a limited field. J Bone Joint Surg Am 74 (1992) 186
55. Tucker M.A., D'Angio G.J., Boice Jr. J.D., et al. Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med 317 (1987) 588
56. Ron E., Modan B., Boice Jr. J.D., et al. Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med 319 (1988) 1033
57. Kim J.H., Chu F.C., Woodard H.Q., et al. Radiation-induced soft-tissue and bone sarcoma. Radiology 129 (1978) 501
58. Arlen M., Higinbotham N.L., Huvos A.G., et al. Radiation-induced sarcoma of bone. Cancer 28 (1971) 1087
59. Cornes P.G., Shahidi M., and Glees J.P. Heterotopic bone formation: irradiation of high risk patients. Br J Radiol 75 (2002) 448
60. Pakos E.E., and Ioannidis J.P. Radiotherapy vs. nonsteroidal anti-inflammatory drugs for the prevention of heterotopic ossification after major hip procedures: a meta-analysis of randomized trials. Int J Radiat Oncol Biol Phys 60 (2004) 888
61. Pakos E.E., Pitouli E.J., Tsekeris P.G., et al. Prevention of heterotopic ossification in high-risk patients with total hip arthroplasty: the experience of a combined therapeutic protocol. Int Orthop 30 (2006) 79
62. Horwitz B.R., Rockowitz N.L., Goll S.R., et al. A prospective randomized comparison of two surgical approaches to total hip arthroplasty. Clin Orthop Relat Res (1993) 154
63. Pai V.S. Heterotopic ossification in total hip arthroplasty. The influence of the approach. J Arthroplasty 9 (1994) 199
64. Maloney W.J., Krushell R.J., Jasty M., et al. Incidence of heterotopic ossification after total hip replacement: effect of the type of fixation of the femoral component. J Bone Joint Surg Am 73 (1991) 191
65. Purtill J.J., Eng K., Rothman R.H., et al. Heterotopic ossification. Incidence in cemented versus cementless total hip arthroplasty. J Arthroplasty 11 (1996) 58
66. Nayak K.N., Mulliken B., Rorabeck C.H., et al. Prevalence of heterotopic ossification in cemented versus noncemented total hip joint replacement in patients with osteoarthrosis: a randomized clinical trial. Can J Surg 40 (1997) 368
67. Gonzalez Della Valle A., Salonia Ruzo P., Pavone V., et al. Heterotopic ossification after total hip arthroplasty: a critical analysis of the Brooker classification and proposal of a simplified rating system. J Arthroplasty 17 (2002) 870